Norepinephrine (medication) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Norepinephrine (medication)" in English language version.

refsWebsite

Global rank English rank

4^th place

3^rd place

2^nd place

1^st place

399^th place

333^rd place

low place

102^nd place

76^th place

11^th place

8^th place

low place

books.google.com

Latifi R (2016). Surgical Decision Making: Beyond the Evidence Based Surgery. Springer. p. 67. ISBN 9783319298245. Archived from the original on 2017-03-27.
Encyclopedia of the Neurological Sciences. Academic Press. 2014. p. 224. ISBN 9780123851581. Archived from the original on 2017-03-27.
Moore JI (6 December 2012). Pharmacology (3rd ed.). Springer Science and Business Media. p. 39. ISBN 9781468405248. Retrieved 19 November 2017.
Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 885. ISBN 978-1-4757-2085-3. Retrieved 31 August 2024.
Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 874. ISBN 978-3-88763-101-7. Retrieved 31 August 2024.

Klabunde RE (7 December 2022). "Circulating Catecholamines". CV Physiology. Retrieved 2019-02-27.

Andersen AM (1975). "Structural studies of metabolic products of dopamine. IV. Crystal and molecular structure of (-)-noradrenaline". Acta Chemica Scandinavica B. 29 (8): 871–876. doi:10.3891/acta.chem.scand.29b-0871. PMID 1202890.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. (March 2017). "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016". Critical Care Medicine. 45 (3): 486–552. doi:10.1097/CCM.0000000000002255. hdl:10281/267577. PMID 28098591. S2CID 52827184. We recommend norepinephrine as the first-choice vasopressor (strong recommendation, moderate quality of evidence).
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. (March 2010). "Comparison of dopamine and norepinephrine in the treatment of shock". The New England Journal of Medicine. 362 (9): 779–789. doi:10.1056/nejmoa0907118. PMID 20200382.
Froese L, Dian J, Gomez A, Unger B, Zeiler FA (October 2020). "The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literature". Pharmacol Res Perspect. 8 (5): e00655. doi:10.1002/prp2.655. PMC 7510331. PMID 32965778.

"Norepinephrine Bitartrate". The American Society of Health-System Pharmacists. Archived from the original on 26 March 2017. Retrieved 26 March 2017.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. (March 2017). "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016". Critical Care Medicine. 45 (3): 486–552. doi:10.1097/CCM.0000000000002255. hdl:10281/267577. PMID 28098591. S2CID 52827184. We recommend norepinephrine as the first-choice vasopressor (strong recommendation, moderate quality of evidence).

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. (March 2017). "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016". Critical Care Medicine. 45 (3): 486–552. doi:10.1097/CCM.0000000000002255. hdl:10281/267577. PMID 28098591. S2CID 52827184. We recommend norepinephrine as the first-choice vasopressor (strong recommendation, moderate quality of evidence).

Andersen AM (1975). "Structural studies of metabolic products of dopamine. IV. Crystal and molecular structure of (-)-noradrenaline". Acta Chemica Scandinavica B. 29 (8): 871–876. doi:10.3891/acta.chem.scand.29b-0871. PMID 1202890.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. (March 2017). "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016". Critical Care Medicine. 45 (3): 486–552. doi:10.1097/CCM.0000000000002255. hdl:10281/267577. PMID 28098591. S2CID 52827184. We recommend norepinephrine as the first-choice vasopressor (strong recommendation, moderate quality of evidence).
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. (March 2010). "Comparison of dopamine and norepinephrine in the treatment of shock". The New England Journal of Medicine. 362 (9): 779–789. doi:10.1056/nejmoa0907118. PMID 20200382.
Pollard S, Edwin SB, Alaniz C (July 2015). "Vasopressor and Inotropic Management Of Patients With Septic Shock". P & T. 40 (7): 438–450. PMC 4495871. PMID 26185405.
Froese L, Dian J, Gomez A, Unger B, Zeiler FA (October 2020). "The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literature". Pharmacol Res Perspect. 8 (5): e00655. doi:10.1002/prp2.655. PMC 7510331. PMID 32965778.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. (March 2017). "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016". Critical Care Medicine. 45 (3): 486–552. doi:10.1097/CCM.0000000000002255. hdl:10281/267577. PMID 28098591. S2CID 52827184. We recommend norepinephrine as the first-choice vasopressor (strong recommendation, moderate quality of evidence).

"Norepinephrine Bitartrate". The American Society of Health-System Pharmacists. Archived from the original on 26 March 2017. Retrieved 26 March 2017.
Latifi R (2016). Surgical Decision Making: Beyond the Evidence Based Surgery. Springer. p. 67. ISBN 9783319298245. Archived from the original on 2017-03-27.
Encyclopedia of the Neurological Sciences. Academic Press. 2014. p. 224. ISBN 9780123851581. Archived from the original on 2017-03-27.